Moreover, the findings indicate that Nrf2 activation and its downstream signalling pathway interact with the activation of NFκB-mediated inflammatory responses in diabetes, and genistein supplementation might reduce activation of antioxidant defence systems and inflammatory responses by regulation of Nrf2 and NFκB interactions. Here, NFKB1 is linked to diabetes mellitus.